(Reuters) – Boston Scientific Corp agreed to pay nearly $189 million to settle claims by most U.S. states that it misled consumers about the safety and effectiveness of its surgical mesh devices.
The settlement with 47 states and Washington, D.C. was announced on Tuesday by multiple state attorneys general.
(Reporting by Jonathan Stempel in New York)
